Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: from PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccines.

petosemtamab (MCLA-158) - Genmab

ficerafusp alfa (BCA101) - Bicara Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42144173

Alessandra Cassano; Antonio Bassolino; Armando Di Bello; Giampaolo Tortora; Lucia Del Mastro; Marianna Caterino; Morena Fasano; Renato Falcicchia; Riccardo Gili; Sara Polidori

May 18, 2026